Details for Patent: 11,679,116
✉ Email this page to a colleague
Which drugs does patent 11,679,116 protect, and when does it expire?
Patent 11,679,116 protects ARAZLO and is included in one NDA.
This patent has twenty-seven patent family members in nineteen countries.
Drugs Protected by US Patent 11,679,116
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ARAZLO | tazarotene | LOTION;TOPICAL | 211882-001 | Dec 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,679,116
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016279801 | ⤷ Try a Trial | |||
Brazil | 112017027332 | ⤷ Try a Trial | |||
Brazil | 112019023817 | ⤷ Try a Trial | |||
Canada | 2988577 | ⤷ Try a Trial | |||
Canada | 3063371 | ⤷ Try a Trial | |||
China | 108282998 | ⤷ Try a Trial | |||
Cyprus | 1123354 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |